BP10032
|
Tubeimoside I
|
|
|
|
Tubeimoside I(Lobatoside-H) is an extract from Chinese herbal medicine Bolbostemma paniculatum (MAXIM).
|
BP10150
|
tubuloside B
|
|
|
|
The neuroprotective effect of tubuloside B, one of the phenylethanoids isolated from the stems of Cistanche salsa, on tumor necrosis factor-alpha (TNFalpha)-induced apoptosis in SH-SY5Y neuronal cells.
|
BP10625
|
TVB-3166
|
|
|
|
TVB-3166 induces apoptosis and inhibits in-vivo xenograft tumor growth. TVB-3166 is a reversible and selective fatty acid synthase inhibitor (IC50s: 42 nM and 81 nM for biochemical FASN and cellular palmitate synthesis, respectively).
|
BP10205
|
Tyrphostin 23
|
|
|
|
AG-18 inhibits EGFR with IC50 of 35 μM.
|
BP10085
|
Tyrphostin A9
|
|
|
|
Tyrphostin 9 is an Agricultural acaricide, now superseded. Tyrphostin 9 is firstly designed as an EGFR inhibitor
|
BP10555
|
Tyrphostin AG 112
|
|
|
|
Tyrphostin AG 112 is an inhibitor of EGFR phosphorylation.
|
BP10384
|
Tyrphostin AG 528
|
|
|
|
Tyrphostin AG 528 is an inhibitor of EGFR (IC50: 4.9 μM) and ErbB2 (IC50: 2.1 μM).
|
BP10587
|
Tyrphostin AG 879
|
|
|
|
Tyrphostin AG 879 effectively inhibits HER2/ErbB2 (IC50: 1 μM), 100- and 500-fold higher selective to ErbB2 than EGFR and PDGFR.
|
BP10572
|
Tyrphostin AG1296
|
|
|
|
Tyrphostin AG 1296 is an inhibitor of PDGFR with IC50 of 0.3-0.5 μM, no activity to EGFR.
|
BP10737
|
Tyrphostin AG1433
|
|
|
|
Tyrphostin AG1433 is an inhibitor of tyrosine kinases and also a dual inhibitor of PDGFRβ(IC50s = 5.0 μM) and VEGFR-2 (Flk-1/KDR)(IC50s = 9.3 μM).
|
BP10254
|
Tyrphostin AG30
|
|
|
|
Tyrphostin AG30 (AG30) is a potent protein tyrosine kinases (PTK) inhibitor.
|
BP10382
|
Tyrphostin B44, (+) enantiomer
|
|
|
|
Tyrphostin B44, (+) enantiomer is an inhibitor of epidermal growth factor receptor (EGFR) kinase with IC50 of 0.86 μM and has less active than the (-) enantiomer.
|
BP10155
|
U-73122
|
|
|
|
U73122, an effective PLC inhibitor, reduces agonist-induced Ca2+ increases in platelets and PMN.
|
BP10461
|
UC2288
|
|
|
|
UC2288 is a relatively selective p21 attenuator which is synthesized based Sorafenib. UC2288 attenuates p21 protein levels with minimal effect on p21 protein stability.
|
BP10607
|
UCB-9260
|
|
|
|
UCB-9260 inhibits TNF signaling by stabilizing an asymmetric form of the trimer.
|
BP10482
|
UNC1215
|
|
|
|
UNC1215, an effective and specific MBT (malignant brain tumor) antagonist, binds L3MBTL3 (IC50/Kd: 40/120 nM). The selectivity of UNC1215 for L3MBTL3 is 50-fold higher versus other members of the human MBT family.
|
BP10524
|
UNC2025
|
|
|
|
UNC-2025( IC50 of 0.74 nM and 0.8 nM) is a potent and orally bioavailable dual MER/FLT3 inhibitor. UNC-2025 is about 20-fold selectivity higher than Axl and Tyro3.
|
BP10673
|
UNC2541
|
|
|
|
UNC2541 is a potent and Mer tyrosine kinase (MerTK)-specific inhibitor. It also binds in the MerTK ATP pocket (IC50: 4.4 nM). UNC2541 inhibits phosphorylated MerTK (pMerTK; EC50, 510 nM).
|
BP10671
|
Unesbulin
|
|
|
|
PTC596 is an orally active and selective inhibitor of B-cell-specific Moloney murine leukemia virus integration site 1 (BMI-1).
|
BP10358
|
Upadacitinib
|
|
|
|
Upadacitinib (ABT-494) is a selective Janus kinase (JAK) 1 inhibitor, which is being studied for the treatment of several autoimmune disorders in the IC50 of 43 nM.
|